TGFB1 and melanoma: Inhibiting the secretion of TGF-β and IL-10 by reducing the number of Tregs in the spleens of melanoma mice (0.13 and 0.3 g/kg, respectively, of 0.2 mL once a day for 14 days, i.g.)